Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1595888 NEW YORK, NY
Back to TGTX Full portfolio

Position in TGTX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$67,824,242
+$38,909,289 QoQ
Shares Held
2,041,669
+110.5% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Derivatives in TGTX

reported options exposure · as of Mar 31, 2026
CallValue
$3,783,758
CallShares
113,900
PutValue
$33,063,866
PutShares
995,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,247,243,084 across 314 Biotechnology names. TGTX ranks #3 (5.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,757,672 $130,524,721
2 RPRX
Royalty Pharma plc
 2,400,382 $115,146,324
3 TGTX
Tg Therapeutics, Inc.
This page 		2,041,669 $67,824,242
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 122,946 $54,900,305
5 HALO
Halozyme Therapeutics, Inc.
 831,707 $53,753,223
6 EXEL
Exelixis, Inc.
 1,087,030 $46,622,715
7 JAZZ
Jazz Pharmaceuticals plc
 223,615 $42,274,415
8 BNTX
BioNTech SE
 336,757 $29,930,962

All Filings in TGTX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $33,063,866 995,300
2026-03-31 $67,824,242 2,041,669
2026-03-31 $3,783,758 113,900
2025-12-31 $20,548,033 689,300
2025-12-31 $28,914,953 969,975
2025-12-31 $4,689,113 157,300
2025-09-30 $40,776,453 1,128,760
2025-09-30 $14,395,812 398,500
2025-09-30 $9,258,837 256,300
2025-06-30 $25,373,381 705,012
2025-06-30 $8,968,708 249,200
2025-06-30 $8,842,743 245,700
2025-03-31 $12,227,243 310,100
2025-03-31 $14,163,019 359,194
2025-03-31 $12,570,284 318,800
2024-12-31 $865,012 28,738
2024-12-31 $13,219,920 439,200
2024-12-31 $15,898,820 528,200
2024-09-30 $7,335,104 313,600
2024-09-30 $1,809,846 77,377
2024-09-30 $4,521,287 193,300
2024-06-30 $7,383,969 415,063
2024-03-31 $3,411,023 224,262
2023-12-31 $10,161,318 594,925
2023-09-30 $3,713,536 444,203
2023-06-30 $16,545,203 666,071
2023-03-31 $2,890,115 192,162
2022-12-31 $8,196,438 692,852
2022-09-30 $2,995,033 505,918
2022-06-30 $1,947,180 458,160
2022-03-31 $1,702,290 179,000
2022-03-31 $2,901,501 305,100
2022-03-31 $3,462,780 364,120
2021-12-31 $3,416,181 179,799
2021-12-31 $3,545,400 186,600
2021-12-31 $4,208,500 221,500
2021-09-30 $10,919,300 328,104
2021-09-30 $7,973,888 239,600
2021-09-30 $4,399,616 132,200
2021-06-30 $12,246,778 315,720
2021-06-30 $7,094,691 182,900
2021-06-30 $3,079,926 79,400
2021-03-31 $5,302,000 110,000
2021-03-31 $6,960,080 144,400
2021-03-31 $8,813,418 182,851
2020-12-31 $3,480,138 66,900
2020-12-31 $17,052,156 327,800
2020-12-31 $4,369,731 84,001
2020-09-30 $2,156,856 80,600
2020-09-30 $5,954,100 222,500

Report a Problem

Category
Description
Email (optional, for follow-up)